Appeal No. 1997-2436 Application No. 08/232,014 interface between said water phase and said oil phase either of a water-in-oil emulsion or an oil-in-water emulsion, and forming said nanocapsules or nanoparticles from said nanoemulsion, wherein an interfacial crosslinking reaction is carried out, between said protein and a crosslinking agent having reactive groups capable of reacting at said interface with said acylatable groups of said protein, so as to yield said nanocapsules with crosslinked protein-based walls. 24. A process for the production of nanocapsules, with cross-linked protein- based walls, which comprises preparing a nanoemulsion of said proteins comprising an oil phase and a water phase, defining an interface between said water phase and said oil phase either of a waste-in-oil emulsion or of an oil-in-water emulsion and forming said nanocapsules from said nanoemulsion, wherein an interfacial cross-linking reaction is carried out between said proteins and a cross-linking agent selected from the group consisting of an acid dichloride, an acid anhydride and a dibasic or polybasic carboxylic acid, as to yield said nanocapsules, with cross-linked protein-based walls. 36. A nanocapsule or nanoparticle having a size of less than 800 nM comprising a crosslinked outer wall having been obtained from a nanoemulsion by an interfacial crosslinking reaction between at least one protein having acylatable groups and a crosslinking agent having reactive groups capable of reacting with said acylatable groups of said protein to form interfacial crosslinking. The reference relied upon by the examiner is: Huc et al. (Huc) 5,395,620 March 7, 1995 (Filed June 8, 1993) Grounds of Rejection Claims 3-7, 11, 14-17, 21-29, 31, 34, 36-44, 46, and 47 stand rejected under 35 U.S.C. § 102 (e). As evidence of anticipation, the examiner relies upon Huc. Claims 3-50 stand rejected under 35 U.S.C. § 103. As evidence of obviousness the examiner relies upon Huc. 2Page: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007